AN UPDATE ON CLINICAL AND ECONOMIC EVIDENCE REQUIREMENTS FOR ADVANCED-THERAPY MEDICINAL PRODUCTS IN EUROPE

被引：2
作者：
Anastasaki, E. [1 ]
Walker, A. [2 ]
Bradshaw, S. [1 ]
机构：
[1] Market Access Solut LLC, London, England
[2] Univ Glasgow, Glasgow, Lanark, Scotland
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
10.1016/j.jval.2014.08.1176
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PHP240
引用
收藏
页码：A444 / A444
页数：1
相关论文
共 50 条
  • [1] Clinical Development of Advanced Therapy Medicinal Products in Europe: Evidence That Regulators Must Be Proactive
    Maciulaitis, Romaldas
    D'Apote, Lucia
    Buchanan, Andrew
    Pioppo, Laura
    Schneider, Christian K.
    MOLECULAR THERAPY, 2012, 20 (03) : 479 - 482
  • [2] REIMBURSEMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2018, 21 : S202 - S203
  • [3] THE REIMBURSEMENT STATUS OF ADVANCED THERAPY MEDICINAL PRODUCTS IN EUROPE
    Hanna, E.
    Marre, C.
    Toumi, M.
    VALUE IN HEALTH, 2019, 22 : S428 - S428
  • [4] Access Challenges of Advanced Therapy Medicinal Products in Europe
    Szulc, E.
    Tschumi, B.
    Pennese, N.
    Lecureuil, C.
    Robbins, S.
    VALUE IN HEALTH, 2022, 25 (12) : S336 - S336
  • [5] Specific guidelines requirements for clinical trials with Advanced Therapy Medicinal Products in the European Union
    Mahalatchimy, A.
    Gennet, E.
    Morrison, M.
    Andrieu, V.
    Veran, J.
    Sabatier, F.
    HUMAN GENE THERAPY, 2022, 33 (23-24) : A197 - A197
  • [6] Clinical trials with advanced therapy medicinal products
    Schuessler-Lenz, M.
    Schneider, C. K.
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2010, 53 (01) : 68 - 74
  • [7] HTA REQUIREMENTS FOR ADVANCED THERAPY MEDICINAL PRODUCTS (ATMPS) IN GERMANY
    Dose, J.
    Eheberg, D.
    Hinnenthal, M.
    Schuh, I
    Unterweger, A.
    Bonduelle, D.
    VALUE IN HEALTH, 2022, 25 (01) : S171 - S171
  • [8] The regulation of advanced therapy medicinal products in Europe and the role of academia
    Lowdell, M. W.
    Pearce, K. F.
    Apperley, J.
    Dickinson, A. M.
    Edinger, M.
    Greinix, H.
    Hauser, A.
    Koehl, U.
    Mischak-Weissinger, E.
    Scheding, S.
    Worel, N.
    Hildebrandt, M.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S510 - S510
  • [9] Regulation of advanced therapy medicinal products in Europe and the role of academia
    Pearce, Kim F.
    Hildebrandt, Martin
    Greinix, Hildegard
    Scheding, Stefan
    Koehl, Ulrike
    Worel, Nina
    Apperley, Jane
    Edinger, Matthius
    Hauser, Andrea
    Mischak-Weissinger, Eva
    Dickinson, Anne M.
    Lowdell, Mark W.
    CYTOTHERAPY, 2014, 16 (03) : 289 - 297
  • [10] Advanced Therapy Medicinal Products' Translation in Europe: A Developers' Perspective
    Pizevska, Maja
    Kaeda, Jaspal
    Fritsche, Enrico
    Elazaly, Hisham
    Reinke, Petra
    Amini, Leila
    FRONTIERS IN MEDICINE, 2022, 9
12345